Xceleron Attracts Existing investors for Further Funds

By Angela Sormani — 4 years ago

Xceleron, a company which accelerates drug development using ultra-sensitive bioanalytical analyses, has attracted existing investors Albion Ventures and Solon Ventures to invest $2.4MM to locate all of the company’s business in its custom-built facility in Germantown, MD. Xceleron was founded in 1997 in York, UK. In 2008, the company opened its US facility in Maryland. […]